BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7728569)

  • 1. Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta.
    Peplinski GR; Tsung K; Whitman ED; Meko JB; Norton JA
    Ann Surg Oncol; 1995 Mar; 2(2):151-9. PubMed ID: 7728569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta.
    Peplinski GR; Tsung K; Meko JB; Norton JA
    Surgery; 1995 Aug; 118(2):185-90; discussion 190-1. PubMed ID: 7638732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta.
    Peplinski GR; Tsung AK; Casey MJ; Meko JB; Fredrickson TN; Buller RM; Norton JA
    Cancer J Sci Am; 1996; 2(1):21-7. PubMed ID: 9166494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12.
    Meko JB; Tsung K; Norton JA
    Surgery; 1996 Aug; 120(2):274-82; discussion 282-3. PubMed ID: 8751593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of murine breast cancer by vaccination with tumor cells modified by cytokine-producing recombinant vaccinia viruses.
    Peplinski GR; Tsung K; Meko JB; Norton JA
    Ann Surg Oncol; 1996 Jan; 3(1):15-23. PubMed ID: 8770297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
    Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
    Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution.
    Jackaman C; Nelson DJ
    Cancer Gene Ther; 2010 Jun; 17(6):429-40. PubMed ID: 20150930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.
    Carroll MW; Overwijk WW; Surman DR; Tsung K; Moss B; Restifo NP
    J Natl Cancer Inst; 1998 Dec; 90(24):1881-7. PubMed ID: 9862625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper.
    Timiryasova TM; Chen B; Fodor N; Fodor I
    Biotechniques; 2001 Sep; 31(3):534, 536, 538-40. PubMed ID: 11570497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.
    Byrd CM; Hruby DE
    Methods Mol Biol; 2004; 269():31-40. PubMed ID: 15114005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
    Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
    Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM; Chen B; Fodor I
    J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
    Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
    J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of recombinant vaccinia virus strains using single-stranded DNA insertion vectors.
    Wilson EM; Hodges WM; Hruby DE
    Gene; 1986; 49(2):207-13. PubMed ID: 3569915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fidelity of homologous recombination in vaccinia virus DNA.
    Ball LA
    Virology; 1995 Jun; 209(2):688-91. PubMed ID: 7778303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.
    Meko JB; Yim JH; Tsung K; Norton JA
    Cancer Res; 1995 Nov; 55(21):4765-70. PubMed ID: 7585501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a novel set of transfer vectors to study vaccinia virus replication and foreign gene expression.
    Dvoracek B; Shors T
    Plasmid; 2003 Jan; 49(1):9-17. PubMed ID: 12583996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.